Pages that link to "Q35501693"

The following pages link to Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies (Q35501693):

Displaying 27 items.

• Vitamin D in hematological disorders and malignancies (Q30275725) (← links)
• The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis (Q33577607) (← links)
• C-C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation (Q37125164) (← links)
• Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein (Q37137938) (← links)
• Vitamin D3 Intake Dose and Common Cancer: A Population-Based Case Control Study in a Chinese Population (Q37427940) (← links)
• Longitudinal, observational study on associations between postoperative nutritional vitamin D supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy (Q37498870) (← links)
• Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation. (Q38707181) (← links)
• DNA Repair in Despair-Vitamin D Is Not Fair. (Q38874859) (← links)
• Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma. (Q40070467) (← links)
• Vitamin D deficiency is associated with a poor prognosis in advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy (Q40421674) (← links)
• 1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p (Q41694103) (← links)
• Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia. (Q42011055) (← links)
• Hodgkin Lymphoma has a seasonal pattern of incidence and mortality that depends on latitude (Q45048570) (← links)
• Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy. (Q47260924) (← links)
• Current prognostic and predictive factors in follicular lymphoma (Q48185856) (← links)
• Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies (Q49540308) (← links)
• Unmet needs in the first-line treatment of follicular lymphoma (Q50710717) (← links)
• Vitamin D deficiency is associated with inferior survival of patients with extranodal natural killer/T-cell lymphoma (Q57806359) (← links)
• Vitamin D and its receptor polymorphisms: New possible prognostic biomarkers in leukemias (Q58580750) (← links)
• Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications (Q58757535) (← links)
• Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis (Q59805381) (← links)
• Calcitriol and cancer therapy: A missed opportunity (Q61023219) (← links)
• Combination of lenalidomide and vitamin D enhances MOR202-mediated cytotoxicity of macrophages: It takes three to tango (Q61810406) (← links)
• Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy (Q87343175) (← links)
• 25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it? (Q87984564) (← links)
• Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway (Q88355804) (← links)
• The Vitamin D status is associated with serum C-reactive protein and adhesion molecules in patients with renal cell carcinoma (Q91272464) (← links)